Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Chiaretti

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|October 21, 2020
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in AdultsRobin Foà, Renato Bassan, Antonella Vitale, et al.
Plos One|August 1, 2012
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemiaIlaria Iacobucci, Nunzio Iraci, Monica Messina, et al.
British Journal of Haematology|September 13, 2023
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL studyDarina Ocadlikova, Federico Lussana, Nicola Fracchiolla, et al.
Leukemia Research|September 26, 2022
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all groupMarzia Defina, Davide Lazzarotto, Fabio Guolo, et al.
Blood|July 25, 2008
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistanceIlaria Iacobucci, Annalisa Lonetti, Francesca Messa, et al.
The Journal of Molecular Diagnostics : JMD|June 16, 2022
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic LeukemiaIrene Della Starza, Lucia A De Novi, Alessandra Santoro, et al.
British Journal of Haematology|April 21, 2018
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implicationsSabina Chiaretti, Monica Messina, Sara Grammatico, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 9, 2012
Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategiesMaria Rosaria Ricciardi, Maria Cristina Scerpa, Paola Bergamo, et al.
Haematologica|February 4, 2021
A multicenter total therapy strategy for <i>de novo</i> adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocolSabina Chiaretti, Michela Ansuinelli, Antonella Vitale, et al.
Haematologica|October 5, 2023
BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life studyFrancesco Malfona, Ilaria Tanasi, Matteo Piccini, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|October 21, 2020
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in AdultsRobin Foà, Renato Bassan, Antonella Vitale, et al.
Plos One|August 1, 2012
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemiaIlaria Iacobucci, Nunzio Iraci, Monica Messina, et al.
British Journal of Haematology|September 13, 2023
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL studyDarina Ocadlikova, Federico Lussana, Nicola Fracchiolla, et al.
Leukemia Research|September 26, 2022
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all groupMarzia Defina, Davide Lazzarotto, Fabio Guolo, et al.
Blood|July 25, 2008
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistanceIlaria Iacobucci, Annalisa Lonetti, Francesca Messa, et al.
The Journal of Molecular Diagnostics : JMD|June 16, 2022
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic LeukemiaIrene Della Starza, Lucia A De Novi, Alessandra Santoro, et al.
British Journal of Haematology|April 21, 2018
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implicationsSabina Chiaretti, Monica Messina, Sara Grammatico, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 9, 2012
Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategiesMaria Rosaria Ricciardi, Maria Cristina Scerpa, Paola Bergamo, et al.
Haematologica|February 4, 2021
A multicenter total therapy strategy for <i>de novo</i> adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocolSabina Chiaretti, Michela Ansuinelli, Antonella Vitale, et al.
Haematologica|October 5, 2023
BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life studyFrancesco Malfona, Ilaria Tanasi, Matteo Piccini, et al.
Pageof 18